首页   按字顺浏览 期刊浏览 卷期浏览 Calcitriol (1α,25-Dihydroxyvitamin D3) Ointment in Psoriasis, a Safety Tolerance and Ef...
Calcitriol (1α,25-Dihydroxyvitamin D3) Ointment in Psoriasis, a Safety Tolerance and Efficacy Multicentre Study

 

作者: J.M. Wishart,  

 

期刊: Dermatology  (Karger Available online 1994)
卷期: Volume 188, issue 2  

页码: 135-139

 

ISSN:1018-8665

 

年代: 1994

 

DOI:10.1159/000247118

 

出版商: S. Karger AG

 

关键词: Calcitriol;Psoriasis;Safety;Tolerance

 

数据来源: Karger

 

摘要:

30 patients were treated with daily application of calcitriol (1α,25-dihydroxy-vitamin D3) ointment 15 μg/g in white petrolatum. The patients were divided into three groups according to the size of their total area of psoriasis. They were treated for 6 weeks, and investigated first with weekly and then with two-weekly estimations of calcium metabolism (serum calcium, 24-hour urinary calcium, parathyroid hormone, 25-hydroxyvitamin D3 and calcitriol). Ninety percent of the patients cleared or improved and there were no significant side effects or local intolerance. Cosmetic acceptance was good. No clinically significant changes in calcium metabolism were observed in spite of calcitriol application ranging between 73.98 and 306.10 μg daily (normal daily synthesis being 1–2

 

点击下载:  PDF (1892KB)



返 回